09:59 AM EDT, 04/03/2025 (MT Newswires) -- Covalon Technologies ( CVALF ) up 2.7% on last look, on Thursday confirmed that its wound care products will not be impacted by the April 2 tariff announcements by U.S. President Donald Trump.

Under the United States-Mexico-Canada Agreement (USMCA), certain products are not subject to the recent tariffs. Covalon's ( CVALF ) products, produced in Canada and compliant with USMCA guidelines, qualify for full exemption from the tariffs.

"Covalon ( CVALF ) relies on a mix of manufacturing in Canada and the United States for the vast majority of its life-saving, highly innovative medical products. We're pleased to confirm that our Canadian-manufactured products are not subject to U.S. tariffs under the current trade policy," said Brent Ashton, chief executive officer. "This allows us to maintain competitive pricing and uninterrupted access for our highly differentiated products to customers in the United States."

The company, which specializes in advanced wound care collagen dressing, noted that most of its competitors are from the United Kingdom, Germany or China where U.S. import tariffs will be 10%, 20% and 54%, respectively.

Covalon ( CVALF ) was last seen up $0.06, to $2.26, on the TSX Venture Exchange.

Price: 2.21, Change: +0.01, Percent Change: +0.45